Parallax Volatility Advisers, L.P. Genprex, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $53.5 Billion
- Q3 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Genprex, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 19,500 shares of GNPX stock, worth $16,185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,500Holding current value
$16,185% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GNPX
# of Institutions
2Shares Held
600Call Options Held
0Put Options Held
0About Genprex, Inc.
- Ticker GNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,300
- Market Cap $39.9M
- Description
- Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...